Disclosure 0001283303-26-000010-2

SEC FORM 4

$1,359,971.11

Travere Therapeutics, Inc. (TVTX)

Sale of 21,926 shares at $62.0255 per share.

Reporting Person REED ELIZABETH E · Officer Title Chief Legal Officer and GC · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001283303-26-000010 · filed 2026-09-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Travere Therapeutics, Inc. (TVTX)." Disclosed 2026-09-17. https://desqlong.com/cards/0001283303-26-000010-2 (retrieved 2026-09-26).